Molecular Biology Reports Genetics
Microenvironment induces differential reprogramming in breast cancer cell lines through TGF-β and estrogen receptor
Abstract
Background Breast cancer is a leading cause of death among women worldwide. Cancer reprogramming aims to control the behavior of cancer cells by inducing apoptosis, senescence, or differentiation. Targeting several cancer-related pathways is not sufficient for complete reprogramming, while using the embryonic and amphibian oocyte extracts induces growth arrest and dormancy, respectively. Since growth factors and signaling molecules present in human oocyte extract (OE) are likely more compatible with the human cellular environment, this study aims to investigate the potential of human OE to reprogram breast cancer cell lines. This may enhance the efficiency of reprogramming. Methods and Results Cancer reprogramming was evaluated in two breast cancer cell lines: MCF-7 and MDA-MB-231, with and without treatment with human OE for 4 days. We assessed the changes in cells’ proliferation, migration, cell cycle progression, apoptosis, stemness, dormancy, and ultrastructure. We further investigated the underlying mechanism. OE reduced the apoptotic potential, cell cycle progression, and migration, while enhancing stemness and dormancy in MDA-MB-231. In MCF-7, the extract decreased apoptotic potential, stemness, and dormancy, while promoting migration. Conclusions OE induces dormancy-like features in MDA-MB-231 cells while promoting progression in MCF-7 cells. Such differences may arise due to the interplay between the TGF-β pathway, estrogen receptor, and p53 status. Our findings hold promise as an adjuvant therapy in the treatment of triple-negative breast cancer, aiming to minimize patient symptoms and prevent metastasis.